Inventor · disambiguated record
John Anthony Zuris
Also filed as: ZURIS JOHN · ZURIS JOHN ANTHONY
14 granted patents·14 pending applications·508 citations·filing 2014–2025
93Inventor score
Files withEDITAS MEDICINE INC15HARVARD COLLEGE7MASSACHUSETTS EYE & EAR INFIRMARY5SHORELINE BIOSCIENCES INC1
Top patents by PatentIndex Score
28 records- 0198US10912833B2Delivery of negatively charged proteins using cationic lipidsHARVARD COLLEGE·Filed 2018·Granted Feb 9, 2021·66 cites·18 claims
- 0298US10682410B2Delivery system for functional nucleasesHARVARD COLLEGE·Filed 2014·Granted Jun 16, 2020·83 cites·30 claims
- 0398US9737604B2Use of cationic lipids to deliver CAS9HARVARD COLLEGE·Filed 2014·Granted Aug 22, 2017·140 cites·25 claims
- 0498US9526784B2Delivery system for functional nucleasesHARVARD COLLEGE·Filed 2014·Granted Dec 27, 2016·123 cites·24 claims
- 0597US9999671B2Delivery of negatively charged proteins using cationic lipidsHARVARD COLLEGE·Filed 2014·Granted Jun 19, 2018·76 cites·29 claims
- 0694US11071790B2Method for efficient delivery of therapeutic molecules in vitro and in vivoMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Jul 27, 2021·13 cites·11 claims
- 0790US11236313B2Cas9 fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2017·Granted Feb 1, 2022·4 cites·14 claims
- 0888US10258697B2Efficient delivery of therapeutic molecules in vitro and in vivoMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Apr 16, 2019·3 cites·4 claims
- 0975US12102691B2Methods for efficient delivery of therapeutic molecules in vitro and in vivoMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2021·Granted Oct 1, 2024·0 cites·23 claims
- 1075US12043653B2Efficient delivery of therapeutic molecules to cells of the inner earMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2022·Granted Jul 23, 2024·0 cites·23 claims
- 1175US2021315994A1Delivery of negatively charged proteins using cationic lipidsHARVARD COLLEGE·Filed 2020·Application pending·0 cites
- 1273US12049651B2Cas9 fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2021·Granted Jul 30, 2024·0 cites·18 claims
- 1372US2024117383A1Selection by essential-gene knock-inEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1471US2020323984A1Delivery system for functional nucleasesHARVARD COLLEGE·Filed 2020·Application pending·0 cites
- 1570US2025179488A1Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2024·Application pending·0 cites
- 1668US2025297288A1Genome editing of b cellsEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1767US2025305003A1Genome editing of cellsEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1864US2025025572A1Engineered crispr/cas12a effector proteins, and uses thereofEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 1962US2025320491A1Crispr-cpf1-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2025·Application pending·0 cites
- 2061US2024293543A1Engineered cells for therapyEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 2159US12031132B2Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2020·Granted Jul 9, 2024·0 cites·26 claims
- 2258US2023227856A1Selection by essential-gene knock-inEDITAS MEDICINE INC·Filed 2021·Application pending·0 cites
- 2357US12325854B2Crispr-CPF1-related methods, compositions and components for cancer immunotherapyEDITAS MEDICINE INC·Filed 2018·Granted Jun 10, 2025·0 cites·9 claims
- 2455US11370823B2Efficient delivery of therapeutic molecules to cells of the inner earMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Jun 28, 2022·0 cites·7 claims
- 2555US2024254444A1Engineered cells for therapySHORELINE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2654US2022025363A1Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 2750US2020299661A1Cpf1-related methods and compositions for gene editingEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 2848US2024191197A1Modified cells and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Anthony Zuris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →